New Results
Immune responses in pancreatic cancer may be restricted by prevalence of activated regulatory T-cells, dysfunctional and senescent T-cells
View ORCID ProfileShivan Sivakumar, View ORCID ProfileEnas Abu-Shah, View ORCID ProfileDavid J Ahern, View ORCID ProfileEdward H Arbe-Barnes, View ORCID ProfileNagina Mangal, View ORCID ProfileSrikanth Reddy, Aniko Rendek, Alistair Easton, Elke Kurz, Michael Silva, Zahir Soonawalla, View ORCID ProfileLara R Heij, View ORCID ProfileRachael Bashford-Rogers, View ORCID ProfileMark R Middleton, View ORCID ProfileMichael L Dustin
doi: https://doi.org/10.1101/2020.06.20.163071
Shivan Sivakumar
1Department of Oncology, University of Oxford, Oxford OX3 7DQ, UK
2Kennedy Institute of Rheumatology, University of Oxford, Oxford OX3 7FY, UK
3Oxford University Hospitals NHS Foundation Trust, Oxford, UK
Enas Abu-Shah
2Kennedy Institute of Rheumatology, University of Oxford, Oxford OX3 7FY, UK
4Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, UK
David J Ahern
2Kennedy Institute of Rheumatology, University of Oxford, Oxford OX3 7FY, UK
Edward H Arbe-Barnes
5University of Oxford Medical School
Nagina Mangal
6Nuffield Department of Surgical Sciences, University of Oxford, Oxford OX3 9DU, UK
Srikanth Reddy
3Oxford University Hospitals NHS Foundation Trust, Oxford, UK
Aniko Rendek
3Oxford University Hospitals NHS Foundation Trust, Oxford, UK
Alistair Easton
1Department of Oncology, University of Oxford, Oxford OX3 7DQ, UK
Elke Kurz
2Kennedy Institute of Rheumatology, University of Oxford, Oxford OX3 7FY, UK
Michael Silva
3Oxford University Hospitals NHS Foundation Trust, Oxford, UK
Zahir Soonawalla
3Oxford University Hospitals NHS Foundation Trust, Oxford, UK
Lara R Heij
7Department of General, Gastrointestinal, Hepatobiliary and Transplant Surgery, RWTH Aachen University Hospital, Aachen Germany
8Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany
Rachael Bashford-Rogers
9Wellcome Trust Centre for Human Genomics, University of Oxford, Oxford OX3 7BN, UK
Mark R Middleton
1Department of Oncology, University of Oxford, Oxford OX3 7DQ, UK
3Oxford University Hospitals NHS Foundation Trust, Oxford, UK
Michael L Dustin
2Kennedy Institute of Rheumatology, University of Oxford, Oxford OX3 7FY, UK
Posted November 11, 2020.
Immune responses in pancreatic cancer may be restricted by prevalence of activated regulatory T-cells, dysfunctional and senescent T-cells
Shivan Sivakumar, Enas Abu-Shah, David J Ahern, Edward H Arbe-Barnes, Nagina Mangal, Srikanth Reddy, Aniko Rendek, Alistair Easton, Elke Kurz, Michael Silva, Zahir Soonawalla, Lara R Heij, Rachael Bashford-Rogers, Mark R Middleton, Michael L Dustin
bioRxiv 2020.06.20.163071; doi: https://doi.org/10.1101/2020.06.20.163071
Immune responses in pancreatic cancer may be restricted by prevalence of activated regulatory T-cells, dysfunctional and senescent T-cells
Shivan Sivakumar, Enas Abu-Shah, David J Ahern, Edward H Arbe-Barnes, Nagina Mangal, Srikanth Reddy, Aniko Rendek, Alistair Easton, Elke Kurz, Michael Silva, Zahir Soonawalla, Lara R Heij, Rachael Bashford-Rogers, Mark R Middleton, Michael L Dustin
bioRxiv 2020.06.20.163071; doi: https://doi.org/10.1101/2020.06.20.163071
Subject Area
Subject Areas
- Biochemistry (11745)
- Bioengineering (8751)
- Bioinformatics (29195)
- Biophysics (14971)
- Cancer Biology (12095)
- Cell Biology (17411)
- Clinical Trials (138)
- Developmental Biology (9421)
- Ecology (14179)
- Epidemiology (2067)
- Evolutionary Biology (18306)
- Genetics (12245)
- Genomics (16802)
- Immunology (11867)
- Microbiology (28083)
- Molecular Biology (11592)
- Neuroscience (60965)
- Paleontology (451)
- Pathology (1870)
- Pharmacology and Toxicology (3238)
- Physiology (4959)
- Plant Biology (10427)
- Synthetic Biology (2885)
- Systems Biology (7339)
- Zoology (1651)